Search: WFRF:(Sakoff Jennette A.) >
Pyrimidyn Compounds :
Pyrimidyn Compounds : Dual-Action Small Molecule Pyrimidine-Based Dynamin Inhibitors
-
McGeachie, Andrew B (author)
-
- Odell, Luke R (author)
- Centre for Chemical Biology, Chemistry, The University of Newcastle, Callaghan, NSW 2308, Australia
-
Quan, Annie (author)
-
show more...
-
Daniel, James A (author)
-
Chau, Ngoc (author)
-
Hill, Timothy A (author)
-
Gorgani, Nick N (author)
-
Keating, Damien J (author)
-
Cousin, Michael A (author)
-
van Dam, Ellen M (author)
-
Mariana, Anna (author)
-
Whiting, Ainslie (author)
-
Perera, Swetha (author)
-
Novelle, Aimee (author)
-
Young, Kelly A (author)
-
Deane, Fiona M (author)
-
Gilbert, Jayne (author)
-
Sakoff, Jennette A (author)
-
Chircop, Megan (author)
-
McCluskey, Adam (author)
-
Robinson, Phillip J (author)
-
show less...
-
(creator_code:org_t)
- 2013-05-30
- 2013
- English.
-
In: ACS Chemical Biology. - : American Chemical Society (ACS). - 1554-8929 .- 1554-8937. ; 8:7, s. 1507-1518
- Related links:
-
https://urn.kb.se/re...
-
show more...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- Dynamin is required for clathrin-mediated endocytosis (CME). Its GTPase activity is stimulated by phospholipid binding to its PH domain, which induces helical oligomerization. We have designed a series of novel pyrimidine-based "Pyrimidyn" compounds that inhibit the lipid-stimulated GTPase activity of full length dynamin I and II with similar potency. The most potent analogue, Pyrimidyn 7, has an IC50 of 1.1 μM for dynamin I and 1.8 μM for dynamin II, making it among the most potent dynamin inhibitors identified to date. We investigated the mechanism of action of the Pyrimidyn compounds in detail by examining the kinetics of Pyrimidyn 7 inhibition of dynamin. The compound competitively inhibits both GTP and phospholipid interactions with dynamin I. While both mechanisms of action have been previously observed separately, this is the first inhibitor series to incorporate both and thereby to target two distinct domains of dynamin. Pyrimidyn 6 and 7 reversibly inhibit CME of both transferrin and EGF in a number of non-neuronal cell lines as well as inhibiting synaptic vesicle endocytosis (SVE) in nerve terminals. Therefore, Pyrimidyn compounds block endocytosis by directly competing with GTP and lipid binding to dynamin, limiting both the recruitment of dynamin to membranes and its activation. This dual mode of action provides an important new tool for molecular dissection of dynamin's role in endocytosis.
Subject headings
- NATURVETENSKAP -- Kemi -- Organisk kemi (hsv//swe)
- NATURAL SCIENCES -- Chemical Sciences -- Organic Chemistry (hsv//eng)
Keyword
- Medicinal Chemistry
- Läkemedelskemi
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
McGeachie, Andre ...
-
Odell, Luke R
-
Quan, Annie
-
Daniel, James A
-
Chau, Ngoc
-
Hill, Timothy A
-
show more...
-
Gorgani, Nick N
-
Keating, Damien ...
-
Cousin, Michael ...
-
van Dam, Ellen M
-
Mariana, Anna
-
Whiting, Ainslie
-
Perera, Swetha
-
Novelle, Aimee
-
Young, Kelly A
-
Deane, Fiona M
-
Gilbert, Jayne
-
Sakoff, Jennette ...
-
Chircop, Megan
-
McCluskey, Adam
-
Robinson, Philli ...
-
show less...
- About the subject
-
- NATURAL SCIENCES
-
NATURAL SCIENCES
-
and Chemical Science ...
-
and Organic Chemistr ...
- Articles in the publication
-
ACS Chemical Bio ...
- By the university
-
Uppsala University